Karl‐Otto Dubowy

702 total citations
16 papers, 435 citations indexed

About

Karl‐Otto Dubowy is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karl‐Otto Dubowy has authored 16 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Epidemiology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karl‐Otto Dubowy's work include Congenital Heart Disease Studies (9 papers), Cardiovascular Function and Risk Factors (6 papers) and Pulmonary Hypertension Research and Treatments (5 papers). Karl‐Otto Dubowy is often cited by papers focused on Congenital Heart Disease Studies (9 papers), Cardiovascular Function and Risk Factors (6 papers) and Pulmonary Hypertension Research and Treatments (5 papers). Karl‐Otto Dubowy collaborates with scholars based in Germany, Austria and United Kingdom. Karl‐Otto Dubowy's co-authors include Brigitte Peters, Samir Sarikouch, Philipp Beerbaum, Dietmar Boethig, Alfred Hager, Winfried Baden, Thomas S. Mir, Helmut Baumgartner, Robert Radke and Gerhard‐Paul Diller and has published in prestigious journals such as Scientific Reports, Heart and Human Mutation.

In The Last Decade

Karl‐Otto Dubowy

16 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl‐Otto Dubowy Germany 11 289 250 204 120 51 16 435
R A Arcilla United States 11 225 0.8× 257 1.0× 156 0.8× 163 1.4× 119 2.3× 23 504
Daniel Forsha United States 14 209 0.7× 281 1.1× 201 1.0× 89 0.7× 57 1.1× 33 503
Marina Verrengia Italy 13 107 0.4× 468 1.9× 69 0.3× 56 0.5× 46 0.9× 28 526
R. P. Beekman Netherlands 8 115 0.4× 130 0.5× 158 0.8× 57 0.5× 29 0.6× 15 265
Ryuichi Kikawada Japan 11 32 0.1× 179 0.7× 74 0.4× 121 1.0× 42 0.8× 42 354
Talvikki Boldt Finland 10 193 0.7× 157 0.6× 135 0.7× 82 0.7× 27 0.5× 18 371
James C. Shelburne United States 8 64 0.2× 198 0.8× 106 0.5× 104 0.9× 26 0.5× 17 330
Richard Nethononda United Kingdom 10 40 0.1× 282 1.1× 95 0.5× 30 0.3× 19 0.4× 17 367
С. В. Иванов Russia 9 59 0.2× 200 0.8× 89 0.4× 100 0.8× 24 0.5× 82 297
T Honda Japan 9 63 0.2× 161 0.6× 92 0.5× 34 0.3× 14 0.3× 32 311

Countries citing papers authored by Karl‐Otto Dubowy

Since Specialization
Citations

This map shows the geographic impact of Karl‐Otto Dubowy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl‐Otto Dubowy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl‐Otto Dubowy more than expected).

Fields of papers citing papers by Karl‐Otto Dubowy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl‐Otto Dubowy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl‐Otto Dubowy. The network helps show where Karl‐Otto Dubowy may publish in the future.

Co-authorship network of co-authors of Karl‐Otto Dubowy

This figure shows the co-authorship network connecting the top 25 collaborators of Karl‐Otto Dubowy. A scholar is included among the top collaborators of Karl‐Otto Dubowy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl‐Otto Dubowy. Karl‐Otto Dubowy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Michel, Miriam, Kai Thorsten Laser, Karl‐Otto Dubowy, Sabine Scholl‐Bürgi, & Erik Michel. (2022). Metabolomics and random forests in patients with complex congenital heart disease. Frontiers in Cardiovascular Medicine. 9. 994068–994068. 5 indexed citations
2.
Michel, Miriam, Karl‐Otto Dubowy, Andreas Entenmann, et al.. (2020). Targeted metabolomic analysis of serum amino acids in the adult Fontan patient with a dominant left ventricle. Scientific Reports. 10(1). 8930–8930. 28 indexed citations
3.
Michel, Miriam, Christina Salvador, Verena Wiedemair, et al.. (2020). Method comparison of HPLC-ninhydrin-photometry and UHPLC-PITC-tandem mass spectrometry for serum amino acid analyses in patients with complex congenital heart disease and controls. Metabolomics. 16(12). 128–128. 9 indexed citations
4.
Michel, Miriam, Karl‐Otto Dubowy, Manuela Zlamy, et al.. (2020). Targeted metabolomic analysis of serum phospholipid and acylcarnitine in the adult Fontan patient with a dominant left ventricle. Therapeutic Advances in Chronic Disease. 11. 1754207807–1754207807. 20 indexed citations
5.
Gaertner, Anna, Baerbel Klauke, Astrid Kassner, et al.. (2020). Cardiomyopathy‐associated mutations in the RS domain affect nuclear localization of RBM20. Human Mutation. 41(11). 1931–1943. 23 indexed citations
6.
Farr, Martin, et al.. (2017). Left Ventricular Noncompaction Cardiomyopathy and Long QT Syndrome, a Common Cause? A Case Report. The Thoracic and Cardiovascular Surgeon. 65(S 02). S111–S142. 1 indexed citations
8.
Orwat, Stefan, Gerhard‐Paul Diller, Aleksander Kempny, et al.. (2015). Myocardial deformation parameters predict outcome in patients with repaired tetralogy of Fallot. Heart. 102(3). 209–215. 105 indexed citations
9.
Rahman, Mohamed Y. Abd El, Axel Rentzsch, Siegrun Mebus, et al.. (2014). Effect of bosentan therapy on ventricular and atrial function in adults with Eisenmenger syndrome. A prospective, multicenter study using conventional and Speckle tracking echocardiography. Clinical Research in Cardiology. 103(9). 701–710. 6 indexed citations
10.
Rentzsch, Axel, Siegrun Mebus, Oliver Miera, et al.. (2014). Left ventricular dysfunction before therapy is predictor for mortality in adult patients with Eisenmenger syndrome. The Thoracic and Cardiovascular Surgeon. 62(S 02). 2 indexed citations
11.
Sarikouch, Samir, Dietmar Boethig, Brigitte Peters, et al.. (2013). Poorer Right Ventricular Systolic Function and Exercise Capacity in Women After Repair of Tetralogy of Fallot. Circulation Cardiovascular Imaging. 6(6). 924–933. 16 indexed citations
13.
Sarikouch, Samir, H. Koerperich, Karl‐Otto Dubowy, et al.. (2011). Impact of Gender and Age on Cardiovascular Function Late After Repair of Tetralogy of Fallot. Circulation Cardiovascular Imaging. 4(6). 703–711. 53 indexed citations
14.
Möller, Peter, Marcus Weitz, Kai Oliver Jensen, et al.. (2009). Exercise capacity of a contemporary cohort of children with hypoplastic left heart syndrome after staged palliation☆☆☆. European Journal of Cardio-Thoracic Surgery. 36(6). 980–985. 20 indexed citations
15.
Dubowy, Karl‐Otto, et al.. (2008). A practical and transferable new protocol for treadmill testing of children and adults*. Cardiology in the Young. 18(6). 615–623. 49 indexed citations
16.
Dubowy, Karl‐Otto, et al.. (2007). Developmental outcome and psychosocial adjustment in children after surgery for congenital heart disease during infancy. Journal of Reproductive and Infant Psychology. 25(2). 139–151. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026